CD44 and neoplasm: This subtype overexpresses M2 macrophagemarkers and exhibits up‐regulation of SPP1‐CD44/CCL13‐ACKR1 interactions, indicatingits role in shaping the immunosuppressive tumour microenvironment and promotingtumour growth in MPLCs.